Home/Filings/4/0001683168-24-004915
4//SEC Filing

Abecassis Michael M 4

Accession 0001683168-24-004915

CIK 0001157075other

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 4:58 PM ET

Size

5.7 KB

Accession

0001683168-24-004915

Insider Transaction Report

Form 4
Period: 2024-04-30
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-04-30+38,00938,009 total
    Exercise: $2.12Exp: 2034-04-30Common Stock (38,009 underlying)
Footnotes (1)
  • [F1]The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis.

Documents

1 file

Issuer

PharmaCyte Biotech, Inc.

CIK 0001157075

Entity typeother

Related Parties

1
  • filerCIK 0001879281

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:58 PM ET
Size
5.7 KB